Britannia Pharmaceuticals
UK - ReadingPharmaceutical
Focus: Britannia Pharmaceuticals is a UK-based specialty pharmaceutical company founded in 1982, focused on neurological treatments with a pipeline concentrated in Parkinson's Disease and opioid-related disorders. The company operates as a focused player in the neurology space with multiple Phase 2/3 programs in clinical development.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Britannia Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Britannia Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
No Intervention
Advanced Parkinson DiseaseClinical Trials (1)
NCT07313176Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease
N/AHelp build intelligence for Britannia Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.